Antistreptococcal treatment of guttate psoriasis: a controlled study

Int J Dermatol. 2008 Sep;47(9):950-2. doi: 10.1111/j.1365-4632.2008.03663.x.

Abstract

Background: The role of streptococcal infection in the initiation of guttate psoriasis is well-recognized. But the treatment results with oral erythromycin and phenoxymethylpenicillin are conflicting.

Objective: Our purpose was to evaluate the effectiveness of these antibiotics in the treatment of streptococcus associated guttate psoriasis comparing with a control group.

Methods: A total of 43 male patients with serologic evidence of a recent streptococcal infection were studied. Their mean age was 21 years (ranged between 19 and 23 years). These 43 patients were randomly allocated into three groups (no treatment group n = 15, erythromycin group n = 14, phenoxymethylpenicillin group n = 14). Both the treatment groups were treated for 14 d. All the groups were followed up for additional 4 weeks.

Results: There were no statistically significant improvement in any group and among the groups.

Conclusion: There was no statistically significant improvement in streptococcus associated guttate psoriasis with or without a course of oral penicillin or erythromycin.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erythromycin / administration & dosage*
  • Follow-Up Studies
  • Humans
  • Male
  • Penicillin V / administration & dosage*
  • Probability
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Psoriasis / microbiology
  • Reference Values
  • Risk Assessment
  • Severity of Illness Index
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Erythromycin
  • Penicillin V